Last reviewed · How we verify
Aclidinium bromide and formoterol — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Aclidinium bromide and formoterol (Aclidinium bromide and formoterol) — AstraZeneca.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Aclidinium bromide and formoterol TARGET | Aclidinium bromide and formoterol | AstraZeneca | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Aclidinium bromide and formoterol CI watch — RSS
- Aclidinium bromide and formoterol CI watch — Atom
- Aclidinium bromide and formoterol CI watch — JSON
- Aclidinium bromide and formoterol alone — RSS
Cite this brief
Drug Landscape (2026). Aclidinium bromide and formoterol — Competitive Intelligence Brief. https://druglandscape.com/ci/aclidinium-bromide-and-formoterol. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab